{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2016", "item": "https://www.patentleaderboard.com/2016/"}, {"@type": "ListItem", "position": 3, "name": "Institut Pasteur", "item": "https://www.patentleaderboard.com/2016/company/institut-pasteur"}, {"@type": "ListItem", "position": 4, "name": "Daniel Ladant", "item": "https://www.patentleaderboard.com/2016/inventor/fl:da_ln:ladant-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DL

Daniel Ladant — 3 Patents in 2016

CNCNRS: 3 patents #7 of 1,156Top 1%
IPInstitut Pasteur: 3 patents #2 of 93Top 3%
GEGenticel: 1 patents #3 of 7Top 45%
LRLudwig Institute For Cancer Research: 1 patents #1 of 30Top 4%
Cachan, FR: #1 of 14 inventorsTop 8%
Overall (2016): #76,038 of 481,213Top 20%
3 Patents 2016

Issued Patents 2016

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
9410139 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens Gilles Dadaglio, Claude Leclerc, Benoit Van den Eynde, Sandra Morel, Cecile Bauche 2016-08-09
9387243 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof Xavier Preville, Claude Leclerc, Benedikt Timmerman 2016-07-12
9370564 Vectors for molecule delivery to CD11b expressing cells Claude Leclerc, Pierre Guermonprez, Nicole Guiso, Nadia Khelef, Cecile Bauche +2 more 2016-06-21